Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

P3 Health Partners (PIII) Capital Expenditures: 2021-2023

Historic Capital Expenditures for P3 Health Partners (PIII) over the last 3 years, with Q4 2023 value amounting to -$212000.0.

  • P3 Health Partners' Capital Expenditures fell 32400.0% to -$212000.0 in Q4 2023 from the same period last year, while for Jun 2024 it was -$212000.0, marking a year-over-year decrease of 11026.14%. This contributed to the annual value of $1.8 million for FY2023, which is 1818.18% down from last year.
  • Per P3 Health Partners' latest filing, its Capital Expenditures stood at -$212000.0 for Q4 2023, which was down 32400.0% from $387000.0 recorded in Q3 2023.
  • In the past 5 years, P3 Health Partners' Capital Expenditures registered a high of $1.2 million during Q2 2021, and its lowest value of -$212000.0 during Q4 2023.
  • For the 3-year period, P3 Health Partners' Capital Expenditures averaged around $612500.0, with its median value being $590088.5 (2021).
  • Within the past 5 years, the most significant YoY rise in P3 Health Partners' Capital Expenditures was 12671.76% (2023), while the steepest drop was 32400.0% (2023).
  • Quarter analysis of 3 years shows P3 Health Partners' Capital Expenditures stood at $299870.0 in 2021, then tumbled by 116.67% to -$50000.0 in 2022, then plummeted by 324.0% to -$212000.0 in 2023.
  • Its Capital Expenditures stands at -$212000.0 for Q4 2023, versus $387000.0 for Q3 2023 and $1.2 million for Q2 2023.